Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
Clinical Science (London, England : 1979)
|
October 1, 1985
Partial isolation and function of the prostacyclin regulating plasma factor
H Deckmyn, C Zoja, J Arnout, et al.
Scandinavian Journal of Medicine & Science in Sports
|
May 13, 2010
Effect of endurance training on blood pressure regulation, biomarkers and the heart in subjects at a higher age
V A Cornelissen, K Goetschalckx, B Verheyden, et al.
Perfusion
|
January 31, 2002
Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass
Somer F De, Belleghem Y Van, F Caes, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 23, 2002
Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass
F De Somer, Y Van Belleghem, F Caes, et al.
Thrombosis and Haemostasis
|
January 1, 1997
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate
K Peerlinck, J Arnout, M Di Giambattista, et al.
Thrombosis and Haemostasis
|
August 28, 2001
Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies
A Le Querrec, J Arnout, D Arnoux, et al.
Coronary Artery Disease
|
March 1, 1995
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs
L Jun, J Arnout, P Vanhove, et al.
Lancet (London, England)
|
May 4, 1985
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients
Y Vanrenterghem, L Roels, T Lerut, et al.
British Journal of Haematology
|
March 1, 1992
A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele
K Peerlinck, J C Eikenboom, H K Ploos Van Amstel, et al.
Drug Metabolism and Drug Interactions
|
June 15, 1999
Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers
A van Hecken, M Depré, K Wynants, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
Clinical Science (London, England : 1979)
|
October 1, 1985
Partial isolation and function of the prostacyclin regulating plasma factor
H Deckmyn, C Zoja, J Arnout, et al.
Scandinavian Journal of Medicine & Science in Sports
|
May 13, 2010
Effect of endurance training on blood pressure regulation, biomarkers and the heart in subjects at a higher age
V A Cornelissen, K Goetschalckx, B Verheyden, et al.
Perfusion
|
January 31, 2002
Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass
Somer F De, Belleghem Y Van, F Caes, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 23, 2002
Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass
F De Somer, Y Van Belleghem, F Caes, et al.
Thrombosis and Haemostasis
|
January 1, 1997
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate
K Peerlinck, J Arnout, M Di Giambattista, et al.
Thrombosis and Haemostasis
|
August 28, 2001
Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies
A Le Querrec, J Arnout, D Arnoux, et al.
Coronary Artery Disease
|
March 1, 1995
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs
L Jun, J Arnout, P Vanhove, et al.
Lancet (London, England)
|
May 4, 1985
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients
Y Vanrenterghem, L Roels, T Lerut, et al.
British Journal of Haematology
|
March 1, 1992
A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele
K Peerlinck, J C Eikenboom, H K Ploos Van Amstel, et al.
Drug Metabolism and Drug Interactions
|
June 15, 1999
Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers
A van Hecken, M Depré, K Wynants, et al.
Page
of 10